Search Results - "Cleverly, A. L."
-
1
Development and validation of a phosphorylated SMAD ex vivo stimulation assay
Published in Biomarkers (01-05-2007)“…Abstract Assessing the pharmacodynamics (PD) of a potential therapeutic through the use of a downstream biomarker is essential. This is traditionally performed…”
Get full text
Journal Article -
2
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Published in Drug design, development and therapy (01-01-2015)“…Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological processes. TGF-β plays an important role in tumorigenesis and…”
Get full text
Journal Article -
3
Phase I study of LY573636-sodium, an acylsulfonamide anti-cancer compound with a novel mechanism of action, administered as 2-hour IV infusion in patients with advanced solid tumors
Published in Journal of clinical oncology (20-06-2007)“…Abstract only 2515 Background: LY573636 -sodium (hereafter referred to as LY573636 ) is a novel anti-cancer compound that induces apoptosis by a…”
Get full text
Journal Article -
4
Sub-lethal effects of tefluthrin on Diabrotica undecimpunctata howardi, Barber: plant protection and larval development
Published in Crop protection (01-08-1997)“…Larval stages of the southern corn rootworm, Diabrotica undecimpunctata howardi (Barber) (Coleoptera: Chrysomelidae), were used to assess the effects of…”
Get full text
Journal Article